XTX Topco’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-24,494
| Closed | -$53.9K | – | 2586 |
|
|
2024
Q4 | $53.9K | Sell |
24,494
-131,806
| -84% | -$290K | ﹤0.01% | 1875 |
|
|
2024
Q3 | $258K | Sell |
156,300
-208,381
| -57% | -$344K | 0.02% | 1284 |
|
|
2024
Q2 | $810K | Buy |
364,681
+321,859
| +752% | +$715K | 0.07% | 441 |
|
|
2024
Q1 | $115K | Buy |
+42,822
| New | +$115K | 0.02% | 1337 |
|
|
2023
Q4 | – | Sell |
-519,129
| Closed | -$509K | – | 1733 |
|
|
2023
Q3 | $509K | Buy |
519,129
+102,377
| +25% | +$100K | 0.09% | 391 |
|
|
2023
Q2 | $579K | Buy |
416,752
+106,971
| +35% | +$149K | 0.1% | 285 |
|
|
2023
Q1 | $493K | Buy |
+309,781
| New | +$493K | 0.1% | 301 |
|
|
2022
Q2 | – | Sell |
-18,686
| Closed | -$87K | – | 922 |
|
|
2022
Q1 | $87K | Buy |
+18,686
| New | +$87K | 0.04% | 534 |
|